Biography

Daniel Reisner focuses on intellectual property, with emphasis on biotechnology, pharmaceuticals, medical devices, telecommunications and networking.

Mr. Reisner has represented numerous large and small companies through trial involving their most important products, including Sanofi, Regeneron, Pfizer, Novartis, Alexion, Medicalgorithmics, Charter Communications and Amazon. His experience includes representing plaintiffs and defendants in both jury and bench trials, ANDA litigation and arbitration proceedings, as well as IP due diligence and transactional matters.